• Mashup Score: 1

    Background The outcome of pancreatic ductal adenocarcinoma (PDAC) is unsatisfactory, and the identification of novel therapeutic targets is urgently needed. Clinical studies on the antisense oligonucleotide that targets clusterin (CLU) expression have been conducted and have shown efficacy in other cancers. We aimed to investigate the effects of CLU in PDAC and the underlying mechanisms with a…

    Tweet Tweets with this article
    • 🧵1/n Starting a new weekly tradition where I'll be exploring a paper from @AnnSurgOncol every Sunday. This weeks work explores a novel target "Clusterin" and its prognostic -> potentially therapeutic role in PDAC. https://t.co/YU3s50PLK7 https://t.co/DwYbVrnrsm

  • Mashup Score: 6

    Follow the links below to access SSO 2022 Virtual Pre-Meeting sessions on the corresponding dates.  If you have any questions or are experiencing technical difficulties please email education@surgonc.org. On-Demand March 3, 2022 4:00 PM – 4:45 PM CST Virtual Upper GI Great Debate: What is the optimal resection for proximal gastric cancer? Click here to … SSO 2022 Virtual Pre-Meeting Read More »

    Tweet Tweets with this article
    • Tune into #SSO2022 tonight for the Sarcoma, Colorectal and Upper GI/Thoracic Virtual Poster Grand Rounds. Check out and vote for exciting work from my friends @FemiSuraju and @UTSWSurgeryLife ’s own #GloriaChang and #JohnKaralis @SocSurgOnc https://t.co/0SvneX7J4p